Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer.
about
Targeting folate receptor alpha for cancer treatmentProfile of farletuzumab and its potential in the treatment of solid tumorsToxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer: A network meta-analysis.Clinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancerTherapeutic targets and new directions for antibodies developed for ovarian cancer.Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancerFolate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.
P2860
Q26744215-ED21046B-1E87-46D2-B20D-38626264D340Q26750431-9E2ECF89-194C-4031-97F4-AE3EDA2E1E8EQ33438344-ABF5502A-8738-467C-B42F-04C34F2AA302Q36728989-AEB396D4-9EC1-4506-A062-6DFB6DC90C03Q37397674-6BED8E13-9ACC-4FE3-B2F0-DE4A68EA42A1Q37408396-F1A13718-BAE1-43B6-A246-63A500A9359CQ38995020-E849BD8D-C623-4AC4-A30F-BDDF09263411Q47926770-04894AFE-2C97-40F2-833C-F6F82C345805Q52647638-EA06A70F-3D3F-46AA-AD3D-0CC4C5146CF5Q55076479-C436D72F-1DF5-479D-8047-2E8C5725DAFE
P2860
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@ast
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@en
type
label
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@ast
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@en
prefLabel
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@ast
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@en
P2093
P2860
P1433
P1476
Phase 1b safety study of farle ...... ive epithelial ovarian cancer.
@en
P2093
Benjamin Schwartz
Charles Schweizer
Danijela Jelovac
Deborah K Armstrong
Kenneth H Kim
Ronald D Alvarez
Susan C Weil
P2860
P304
P356
10.1016/J.YGYNO.2015.11.031
P407
P577
2015-11-28T00:00:00Z